Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Treasury Shares (2021 - 2025)

Biote has reported Treasury Shares over the past 5 years, most recently at $5.5 million for Q4 2025.

  • Quarterly results put Treasury Shares at $5.5 million for Q4 2025, up 7776.61% from a year ago — trailing twelve months through Dec 2025 was $5.5 million (up 7776.61% YoY), and the annual figure for FY2025 was $5.5 million, up 7776.61%.
  • Treasury Shares for Q4 2025 was $9.0 million at Biote, roughly flat from $9.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for BTMD hit a ceiling of $5.5 million in Q2 2025 and a floor of $69827.0 in Q4 2024.
  • Median Treasury Shares over the past 5 years was $912609.0 (2023), compared with a mean of $1.7 million.
  • Peak annual rise in Treasury Shares hit 60.09% in 2025, while the deepest fall reached 0.0% in 2025.
  • Biote's Treasury Shares stood at $5.6 million in 2024, then skyrocketed by 60.09% to $9.0 million in 2025.
  • The last three reported values for Treasury Shares were $5.5 million (Q4 2025), $1.0 million (Q3 2025), and $5.5 million (Q2 2025) per Business Quant data.